Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Wachter

Showing results (11-20 of 281) with videos related to

Pageof 29
Sort By:
Heart (British Cardiac Society)|August 8, 2024
From urinary proteomic signature to individualised pharmacotherapyAnnika Reuser, Rolf Wachter
European Journal of Preventive Cardiology|February 21, 2021
Psychological stress and incidence of atrial fibrillationChristoph Herrmann-Lingen, Rolf Wachter
European Heart Journal|April 13, 2022
Hospitalization for heart failure: a window of opportunityRolf Wachter, Karl-Philipp Rommel
Deutsche Medizinische Wochenschrift (1946)|September 24, 2020
[Update on the diagnosis of HFrEF and HFpEF]Stefanie M Werhahn, Rolf Wachter
The Lancet. Neurology|January 25, 2025
Anticoagulation for patients with device-detected atrial fibrillation and a history of strokeLuciano A Sposato, Rolf Wachter
Journal of the American Heart Association|May 28, 2024
Pivotal Trials Testing the Efficacy of Novel Anticoagulants for Preventing Emerging Cardioembolic Risk EntitiesRolf Wachter, Karl Georg Haeusler
JAMA|July 11, 2013
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--replyFrank Edelmann, Rolf Wachter, Burkert Pieske
Stroke|January 29, 2011
Letter by Wachter et al regarding article "Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke"Rolf Wachter, Raoul Stahrenberg, Klaus Gröschel
Stroke|February 6, 2010
A risk score to predict future atrial fibrillation derived from patients with stroke initially presenting with atrial fibrillation?Raoul Stahrenberg, Rolf Wachter, Klaus Gröschel
Herz|June 8, 2022
Comorbidities in heart failure with preserved ejection fractionAndrea Deichl, Rolf Wachter, Frank Edelmann
Pageof 29

Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
Heart (British Cardiac Society)|August 8, 2024
From urinary proteomic signature to individualised pharmacotherapyAnnika Reuser, Rolf Wachter
European Journal of Preventive Cardiology|February 21, 2021
Psychological stress and incidence of atrial fibrillationChristoph Herrmann-Lingen, Rolf Wachter
European Heart Journal|April 13, 2022
Hospitalization for heart failure: a window of opportunityRolf Wachter, Karl-Philipp Rommel
Deutsche Medizinische Wochenschrift (1946)|September 24, 2020
[Update on the diagnosis of HFrEF and HFpEF]Stefanie M Werhahn, Rolf Wachter
The Lancet. Neurology|January 25, 2025
Anticoagulation for patients with device-detected atrial fibrillation and a history of strokeLuciano A Sposato, Rolf Wachter
Journal of the American Heart Association|May 28, 2024
Pivotal Trials Testing the Efficacy of Novel Anticoagulants for Preventing Emerging Cardioembolic Risk EntitiesRolf Wachter, Karl Georg Haeusler
JAMA|July 11, 2013
Aldosterone inhibition in patients with heart failure with preserved ejection fraction--replyFrank Edelmann, Rolf Wachter, Burkert Pieske
Stroke|January 29, 2011
Letter by Wachter et al regarding article "Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke"Rolf Wachter, Raoul Stahrenberg, Klaus Gröschel
Stroke|February 6, 2010
A risk score to predict future atrial fibrillation derived from patients with stroke initially presenting with atrial fibrillation?Raoul Stahrenberg, Rolf Wachter, Klaus Gröschel
Herz|June 8, 2022
Comorbidities in heart failure with preserved ejection fractionAndrea Deichl, Rolf Wachter, Frank Edelmann
Pageof 29